Highest development stage: Preclinical

Development dropped

Gram-negative activity

Mechanism of Action/Target pathogen: Had similar activity against Gram positives as vancomycin and daptomycin with certain bacterial sp. decaplanin was more potent.

Reason dropped: Likely not taken further because activity was similar to other existing antibiotics

Additional information: Chin NX, Niu WW and Neu HC. Decaplanin, a novel glycopeptide antibiotic. 31st-ICAAC 1991;167.